安信龙保险

Assurant's 15-minute chart triggers KDJ death cross, bearish marubozu pattern.

BMO Capital maintains Outperform rating for Assurant, lowers PT to $246.

Assurant's 15min chart signals MACD death cross, Bollinger Bands expanding downward.

Assurant: Truist Securities Maintains Buy Rating, Raises PT to $280 from $265.

Assurant

Assurant Oversold: A Potential Buy Opportunity for Dividend Investors

Catalyst<ul> <li>Bullish signals are obviously dominant with 3 bullish versus 1 bearish technical indicators.</li> <li>Most analysts rate AIZ Buy or Strong Buy showing broad institutional optimism.</li></ul>Risk<ul> <li>Fund flows show negative trends across all order sizes indicating potential selling pressure.</li> <li>Market expectations tend to be pessimistic despite mixed analyst ratings.</li></ul>

Key Factors

Assurant (AIZ) reported Q4 2025 earnings of $5.61 per share, exceeding estimates by 4.66%, and revenue of $3.35 billion, surpassing forecasts by 1.52%. Shares of AIZ fell 8.65% intraday to $216.01 amid post-earnings volatility and strategic home warranty investments announced by management. BMO Capital lowered its price target for AIZ to $246 while maintaining an Outperform rating, and Truist Securities raised its PT to $280 while keeping a Buy rating.

AIZ News